CBP-1008
CBP-1008 is a folate receptor (FRα) and TRPV6-targeting peptide-drug conjugate linked to MMAE, demonstrating potent antitumor activity in preclinical studies. It is a research tool for investigating advanced solid tumors, including ovarian, breast, and non-small cell lung cancers, in both in vitro and in vivo models.
Product Specifications
Field of Research
Pharmacology & Drug Discovery
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog